WASHINGTON (AP) — Makers of medical tests that have long escaped government oversight will have about four years to show that their new offerings deliver accurate results, under a government rule vigorously opposed by the testing industry.
The regulation finalized Monday by the Food and Drug Administration will gradually phase in oversight of new tests developed by laboratories, a multibillion-dollar industry that regulators say poses growing risks to Americans. The goal is to ensure that new tests for cancer, heart disease, COVID-19, genetic conditions and many other illnesses are safe, accurate and reliable.
“The final rule announced today aims to provide crucial oversight of these tests to help ensure that important health care decisions are made based on test results that patients and health care providers can trust,” said FDA commissioner Robert Califf, in a release.
Related articles:
Related suggestion:
China to Increase Per Capita Sports Area to 2.6 SQM in 2025China Updates Livestreaming Platform Regulations to Protect MinorsXizang commemorates 65th anniversary of democratic reform that ended feudal serfdomChina Focus: China Expands Public Welfare Jobs for Vulnerable Groups in Push for Common ProsperityInterview: China to Unveil Timely Measures to Stabilize Employment: OfficialThailand's starters against China in 2026 FIFA World Cup qualifierMeet China's first corgi police dogChina Rolls out FiveChina to Hold over 200 PopularChina Issues Plan for Development of Traditional Chinese Medicine
2.9314s , 6501.3828125 kb
Copyright © 2024 Powered by FDA brings lab tests under federal oversight in bid to improve accuracy and safety ,Culture Chronicle news portal